{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:13:04Z","timestamp":1761664384599,"version":"3.40.5"},"reference-count":4,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"published-print":{"date-parts":[[2022,2,1]]},"DOI":"10.4274\/tjo.galenos.2021.73004","type":"journal-article","created":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T11:58:22Z","timestamp":1645617502000},"page":"72-74","source":"Crossref","is-referenced-by-count":2,"title":["Dramatic Improvement of Severe Cicatricial Ectropion after Discontinuing Long-Term Erlotinib Therapy in a Patient with Lung Cancer"],"prefix":"10.4274","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7720-9003","authenticated-orcid":false,"given":"Mehmet Serhat","family":"Mangan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2022,2,1]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/j.ophtha.2012.03.002","article-title":"Ocular adverse events of systemic inhibitors of the epidermal growth factor receptor: report of 5 cases","volume":"119","author":"Saint-Jean","year":"2012","unstructured":"1. Saint-Jean A, Sainz de la Maza M, Morral M, Torras J, Quintana R, Molina JJ, Molina-Prat N. Ocular adverse events of systemic inhibitors of the epidermal growth factor receptor: report of 5 cases. Ophthalmology. 2012;119:1798-1802.","journal-title":"Ophthalmology"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/IOP.0b013e31802d97f0","article-title":"Newly recognized ocular side effects of erlotinib","volume":"23","author":"AB","year":"2007","unstructured":"2. Methvin AB, Gausas RE. Newly recognized ocular side effects of erlotinib. Ophthalmic Plast Reconstr Surg. 2007;23:63-65.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/IOP.0b013e31815a124b","article-title":"Periocular cutaneous toxicity and cicatricial ectropion: a potential class effect of antineoplastic agents that inhibit EGFR signaling","volume":"23","author":"BJ","year":"2007","unstructured":"3. Frankfort BJ, Garibaldi DC. Periocular cutaneous toxicity and cicatricial ectropion: a potential class effect of antineoplastic agents that inhibit EGFR signaling. Ophthalmic Plast Reconstr Surg. 2007;23:496-497.","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3315\/jdcr.2015.1203","article-title":"Erlotinib induced ectropion following papulopustular rash","volume":"9","author":"Salman","year":"2015","unstructured":"4. Salman A, Cerman E, Seckin D, Kanitez M. Erlotinib induced ectropion following papulopustular rash. J Dermatol Case Rep. 2015;9:46-48.","journal-title":"J Dermatol Case Rep"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T13:02:28Z","timestamp":1721998948000},"score":1,"resource":{"primary":{"URL":"https:\/\/oftalmoloji.org\/articles\/doi\/tjo.galenos.2021.73004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,1]]},"references-count":4,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,2,1]]},"published-print":{"date-parts":[[2022,2,1]]}},"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2021.73004","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"type":"print","value":"1300-0659"},{"type":"electronic","value":"2147-2661"}],"subject":[],"published":{"date-parts":[[2022,2,1]]}}}